Cencora Cash on Hand 2010-2025 | COR
Cencora cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Cencora cash on hand for the quarter ending March 31, 2025 was $1.978B, a 4.39% decline year-over-year.
- Cencora cash on hand for 2024 was $3.133B, a 20.86% increase from 2023.
- Cencora cash on hand for 2023 was $2.592B, a 23.5% decline from 2022.
- Cencora cash on hand for 2022 was $3.388B, a 33.02% increase from 2021.
| Cencora Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $3,133 |
| 2023 | $2,592 |
| 2022 | $3,388 |
| 2021 | $2,547 |
| 2020 | $4,598 |
| 2019 | $3,374 |
| 2018 | $2,493 |
| 2017 | $2,435 |
| 2016 | $2,742 |
| 2015 | $2,167 |
| 2014 | $1,809 |
| 2013 | $1,231 |
| 2012 | $1,067 |
| 2011 | $1,826 |
| 2010 | $1,658 |
| 2009 | $1,009 |
| Cencora Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,978 |
| 2024-12-31 | $3,224 |
| 2024-09-30 | $3,133 |
| 2024-06-30 | $3,306 |
| 2024-03-31 | $2,069 |
| 2023-12-31 | $2,872 |
| 2023-09-30 | $2,592 |
| 2023-06-30 | $1,389 |
| 2023-03-31 | $1,539 |
| 2022-12-31 | $1,692 |
| 2022-09-30 | $3,388 |
| 2022-06-30 | $3,034 |
| 2022-03-31 | $2,961 |
| 2021-12-31 | $3,169 |
| 2021-09-30 | $2,547 |
| 2021-06-30 | $2,553 |
| 2021-03-31 | $6,641 |
| 2020-12-31 | $4,891 |
| 2020-09-30 | $4,598 |
| 2020-06-30 | $3,420 |
| 2020-03-31 | $3,692 |
| 2019-12-31 | $3,233 |
| 2019-09-30 | $3,374 |
| 2019-06-30 | $3,000 |
| 2019-03-31 | $2,876 |
| 2018-12-31 | $2,540 |
| 2018-09-30 | $2,493 |
| 2018-06-30 | $2,389 |
| 2018-03-31 | $2,091 |
| 2017-12-31 | $3,038 |
| 2017-09-30 | $2,435 |
| 2017-06-30 | $1,311 |
| 2017-03-31 | $2,404 |
| 2016-12-31 | $1,791 |
| 2016-09-30 | $2,742 |
| 2016-06-30 | $1,865 |
| 2016-03-31 | $2,525 |
| 2015-12-31 | $978 |
| 2015-09-30 | $2,167 |
| 2015-06-30 | $2,555 |
| 2015-03-31 | $2,337 |
| 2014-12-31 | $2,299 |
| 2014-09-30 | $1,809 |
| 2014-06-30 | $1,262 |
| 2014-03-31 | $697 |
| 2013-12-31 | $347 |
| 2013-09-30 | $1,231 |
| 2013-06-30 | $1,568 |
| 2013-03-31 | $1,347 |
| 2012-12-31 | $417 |
| 2012-09-30 | $1,067 |
| 2012-06-30 | $1,656 |
| 2012-03-31 | $2,327 |
| 2011-12-31 | $2,370 |
| 2011-09-30 | $1,826 |
| 2011-06-30 | $2,000 |
| 2011-03-31 | $1,912 |
| 2010-12-31 | $1,401 |
| 2010-09-30 | $1,658 |
| 2010-06-30 | $1,311 |
| 2010-03-31 | $1,200 |
| 2009-12-31 | $980 |
| 2009-09-30 | $1,009 |
| 2009-06-30 | $913 |
| 2009-03-31 | $655 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $57.219B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.605B | 27.50 |
| CVS Health (CVS) | United States | $81.948B | 10.19 |
| Elevance Health (ELV) | United States | $76.969B | 9.93 |
| DiDi Global (DIDIY) | China | $24.191B | 25.70 |
| Natera (NTRA) | United States | $21.906B | 0.00 |
| Labcorp Holdings (LH) | United States | $20.893B | 16.95 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.687B | 0.00 |
| CochLear (CHEOY) | Australia | $12.827B | 0.00 |
| Solventum (SOLV) | United States | $12.768B | 13.52 |
| ICON (ICLR) | Ireland | $12.156B | 11.30 |
| Revvity (RVTY) | United States | $11.964B | 20.59 |
| Viatris (VTRS) | United States | $10.704B | 3.68 |
| Medpace Holdings (MEDP) | United States | $9.298B | 24.69 |
| Avantor (AVTR) | United States | $9.254B | 13.45 |
| Sonic Healthcare (SKHHY) | Australia | $8.886B | 0.00 |
| HealthEquity (HQY) | United States | $8.174B | 35.80 |
| Charles River Laboratories (CRL) | United States | $7.829B | 15.34 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.744B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.911B | 28.92 |
| BrightSpring Health Services (BTSG) | United States | $3.571B | 32.76 |
| Sotera Health (SHC) | United States | $3.349B | 19.03 |
| Surgery Partners (SGRY) | United States | $2.825B | 36.73 |
| Alignment Healthcare (ALHC) | United States | $2.645B | 0.00 |
| Organon (OGN) | United States | $2.584B | 2.75 |
| Concentras Parent (CON) | United States | $2.551B | 14.74 |
| GeneDx Holdings (WGS) | United States | $2.356B | 90.72 |
| Ardent Health (ARDT) | United States | $2.027B | 8.64 |
| Progyny (PGNY) | United States | $1.990B | 43.79 |
| PACS (PACS) | United States | $1.932B | 0.00 |
| Premier (PINC) | United States | $1.736B | 13.18 |
| GoodRx Holdings (GDRX) | United States | $1.695B | 33.89 |
| Teladoc Health (TDOC) | United States | $1.460B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.298B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.127B | 8.58 |
| CareDx (CDNA) | United States | $1.121B | 17.50 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.923B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.810B | 7.58 |
| Nutex Health (NUTX) | United States | $0.637B | 9.64 |
| Embecta (EMBC) | United States | $0.612B | 4.12 |
| InnovAge Holding (INNV) | United States | $0.559B | 0.00 |
| SBC Medicals (SBC) | United States | $0.523B | 0.00 |
| LifeMD (LFMD) | United States | $0.512B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.60 |
| Omada Health (OMDA) | $0.455B | 0.00 | |
| So-Young (SY) | China | $0.390B | 0.00 |
| Enhabit (EHAB) | United States | $0.357B | 29.38 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.344B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.321B | 0.00 |
| Oncology Institute (TOI) | United States | $0.279B | 0.00 |
| Beauty Health (SKIN) | United States | $0.241B | 0.00 |
| DocGo (DCGO) | United States | $0.152B | 24.83 |
| Pheton Holdings (PTHL) | China | $0.138B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.107B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| KindlyMD (NAKA) | United States | $0.074B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| ModivCare (MODV) | United States | $0.046B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.023B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |